Glaxo, Shionogi Say HIV Drug Beats Gilead Atripla in Test – Bloomberg

An experimental treatment for HIV developed by GlaxoSmithKline Plc (GSK), Pfizer Inc. (PFE) and Shionogi & Co. (4507) reduced the virus in more people than Gilead Sciences Inc. (GILD)’s Atripla, suggesting it may supplant the world’s best …